PROSPECTIVE-STUDY OF RENAL-TRANSPLANT INFECTIONS IN 50 CONSECUTIVE PATIENTS

被引:34
作者
MARTINEZMARCOS, F
CISNEROS, J
GENTIL, M
ALGARRA, G
PEREIRA, P
AZNAR, J
PACHON, J
机构
[1] UNIV HOSP VIRGEN DEL ROCIO,SERV NEPHROL,E-41013 SEVILLE,SPAIN
[2] UNIV SEVILLE,SCH MED,DEPT MICROBIOL,SEVILLE,SPAIN
关键词
D O I
10.1007/BF02111821
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A prospective study of the frequency timing, etiology and risk factors of infections in renal transplant recipients during the first year after transplantation was conducted in 50 consecutive patients. Neither prophylaxis with trimethoprim-sulfamethoxazole nor antiviral prophylaxis was administered. Two hundred twenty-eight episodes of infection were registered (4.5 per patient), 19 of which were severe. Forty-seven percent of all infectious episodes occurred during the first two months after transplantation. The more frequent infections were bacterial (64%), viral (22%) and fungal (11%). Escherichia coli was the most common agent isolated (n = 36), followed by cytomegalovirus (n = 32). Urinary tract infections were most common (n = 144), especially asymptomatic bacteriuria (n = 106). Surgical reintervention and the use of antilymphocytic globulins were associated with a higher frequency of severe infections (p < 0.05), and invasive candidiasis was associated with allograft loss (p < 0.03). Annual survival rates of patients and allografts were 100% and 94%, respectively. The frequency of mild infections was higher than that observed in other studies using bacterial or viral prophylaxis. Nevertheless, the number of severe infections and the survival rates of patients and allografts were similar to those reported in previous studies.
引用
收藏
页码:1023 / 1028
页数:6
相关论文
共 26 条
[1]   A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ORAL ACYCLOVIR FOR THE PREVENTION OF CYTOMEGALO-VIRUS DISEASE IN RECIPIENTS OF RENAL-ALLOGRAFTS [J].
BALFOUR, HH ;
CHACE, BA ;
STAPLETON, JT ;
SIMMONS, RL ;
FRYD, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (21) :1381-1387
[2]  
BYRD LH, 1978, LANCET, V2, P1167
[3]  
CALNE RY, 1978, LANCET, V2, P1323
[4]   CYCLOSPORINE - A NEW IMMUNOSUPPRESSIVE AGENT FOR ORGAN-TRANSPLANTATION [J].
COHEN, DJ ;
LOERTSCHER, R ;
RUBIN, MF ;
TILNEY, NL ;
CARPENTER, CB ;
STROM, TB .
ANNALS OF INTERNAL MEDICINE, 1984, 101 (05) :667-682
[5]  
Donatsch P, 1981, J Immunoassay, V2, P19, DOI 10.1080/01971528108062989
[6]   A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND-STUDY OF TRIMETHOPRIM-SULFAMETHOXAZOLE FOR PROPHYLAXIS OF INFECTION IN RENAL-TRANSPLANTATION - CLINICAL EFFICACY, ABSORPTION OF TRIMETHOPRIM-SULFAMETHOXAZOLE, EFFECTS ON THE MICROFLORA, AND THE COST-BENEFIT OF PROPHYLAXIS [J].
FOX, BC ;
SOLLINGER, HW ;
BELZER, FO ;
MAKI, DG .
AMERICAN JOURNAL OF MEDICINE, 1990, 89 (03) :255-274
[7]   FUNGAL INFECTION FOLLOWING RENAL-TRANSPLANTATION [J].
GALLIS, HA ;
BERMAN, RA ;
CATE, TR ;
HAMILTON, JD ;
GUNNELLS, JC ;
STICKEL, DL .
ARCHIVES OF INTERNAL MEDICINE, 1975, 135 (09) :1163-1172
[8]   HIGH-INCIDENCE OF TUBERCULOSIS IN RENAL PATIENTS [J].
GARCIALEONI, ME ;
MARTINSCAPA, C ;
RODENO, P ;
VALDERRABANO, F ;
MORENO, S ;
BOUZA, E .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (04) :283-285
[9]   RAPID DETECTION OF CYTOMEGALOVIRUS IN MRC-5-CELLS INOCULATED WITH URINE SPECIMENS BY USING LOW-SPEED CENTRIFUGATION AND MONOCLONAL-ANTIBODY TO AN EARLY ANTIGEN [J].
GLEAVES, CA ;
SMITH, TF ;
SHUSTER, EA ;
PEARSON, GR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1984, 19 (06) :917-919
[10]   PNEUMOCYSTIS-CARINII PNEUMONIA IN RENAL-TRANSPLANT RECIPIENTS TREATED WITH CYCLOSPORINE AND STEROIDS [J].
HARDY, AM ;
WAJSZCZUK, CP ;
SUFFREDINI, AF ;
HAKALA, TR ;
HO, M .
JOURNAL OF INFECTIOUS DISEASES, 1984, 149 (02) :143-147